Due to their extraordinary therapeutic effects, cannabidiol (CBD) edibles are beneficial to users in a variety of ways. These CBD sweets, which come in a number of flavours and textures, provide hemp-based chemicals or cannabis to the body for stress and听depression听alleviation. They are also termed as cannabis-infused goods.
The global Cannabidiol (CBD) Edibles market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cannabidiol (CBD) Edibles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cannabidiol (CBD) Edibles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cannabidiol (CBD) Edibles in Supermarket is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cannabidiol (CBD) Edibles include Isodiol International, Canopy Growth Corporation, Aurora Cannabis, MGC Pharma, Creso Pharma, Cronos Group, Chill Brands, Curaleaf and Green Thumb Industries, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cannabidiol (CBD) Edibles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabidiol (CBD) Edibles.
Report Scope
The Cannabidiol (CBD) Edibles market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cannabidiol (CBD) Edibles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cannabidiol (CBD) Edibles companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Isodiol International
Canopy Growth Corporation
Aurora Cannabis
MGC Pharma
Creso Pharma
Cronos Group
Chill Brands
Curaleaf
Green Thumb Industries
Tilray
Ecofibre Limited
ENDOCA
Elixinol
Folium Biosciences
NuLeaf Naturals
PharmaHemp
Happy Hemp
Purekana
CV Sciences
CHARLOTTE鈥橲 WEB
Colorado Botanicals
PLUS Products Wonders
Balance CBD
Segment by Type
Beverage
Candy
Biscuit
Cake
Others
Segment by Application
Supermarket
Convenience Store
Hospital
Online Sale
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cannabidiol (CBD) Edibles companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cannabidiol (CBD) Edibles 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Beverage
1.2.3 Candy
1.2.4 Biscuit
1.2.5 Cake
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global Cannabidiol (CBD) Edibles 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Supermarket
1.3.3 Convenience Store
1.3.4 Hospital
1.3.5 Online Sale
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cannabidiol (CBD) Edibles 麻豆原创 Perspective (2019-2030)
2.2 Cannabidiol (CBD) Edibles Growth Trends by Region
2.2.1 Global Cannabidiol (CBD) Edibles 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cannabidiol (CBD) Edibles Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Cannabidiol (CBD) Edibles Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Cannabidiol (CBD) Edibles 麻豆原创 Dynamics
2.3.1 Cannabidiol (CBD) Edibles Industry Trends
2.3.2 Cannabidiol (CBD) Edibles 麻豆原创 Drivers
2.3.3 Cannabidiol (CBD) Edibles 麻豆原创 Challenges
2.3.4 Cannabidiol (CBD) Edibles 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cannabidiol (CBD) Edibles Players by Revenue
3.1.1 Global Top Cannabidiol (CBD) Edibles Players by Revenue (2019-2024)
3.1.2 Global Cannabidiol (CBD) Edibles Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Cannabidiol (CBD) Edibles 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cannabidiol (CBD) Edibles Revenue
3.4 Global Cannabidiol (CBD) Edibles 麻豆原创 Concentration Ratio
3.4.1 Global Cannabidiol (CBD) Edibles 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabidiol (CBD) Edibles Revenue in 2023
3.5 Cannabidiol (CBD) Edibles Key Players Head office and Area Served
3.6 Key Players Cannabidiol (CBD) Edibles Product Solution and Service
3.7 Date of Enter into Cannabidiol (CBD) Edibles 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Cannabidiol (CBD) Edibles Breakdown Data by Type
4.1 Global Cannabidiol (CBD) Edibles Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Cannabidiol (CBD) Edibles Forecasted 麻豆原创 Size by Type (2025-2030)
5 Cannabidiol (CBD) Edibles Breakdown Data by Application
5.1 Global Cannabidiol (CBD) Edibles Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Cannabidiol (CBD) Edibles Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Cannabidiol (CBD) Edibles 麻豆原创 Size (2019-2030)
6.2 North America Cannabidiol (CBD) Edibles 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cannabidiol (CBD) Edibles 麻豆原创 Size by Country (2019-2024)
6.4 North America Cannabidiol (CBD) Edibles 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cannabidiol (CBD) Edibles 麻豆原创 Size (2019-2030)
7.2 Europe Cannabidiol (CBD) Edibles 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cannabidiol (CBD) Edibles 麻豆原创 Size by Country (2019-2024)
7.4 Europe Cannabidiol (CBD) Edibles 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cannabidiol (CBD) Edibles 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Cannabidiol (CBD) Edibles 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cannabidiol (CBD) Edibles 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Cannabidiol (CBD) Edibles 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cannabidiol (CBD) Edibles 麻豆原创 Size (2019-2030)
9.2 Latin America Cannabidiol (CBD) Edibles 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cannabidiol (CBD) Edibles 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Cannabidiol (CBD) Edibles 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cannabidiol (CBD) Edibles 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Cannabidiol (CBD) Edibles 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cannabidiol (CBD) Edibles 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Cannabidiol (CBD) Edibles 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Isodiol International
11.1.1 Isodiol International Company Detail
11.1.2 Isodiol International Business Overview
11.1.3 Isodiol International Cannabidiol (CBD) Edibles Introduction
11.1.4 Isodiol International Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.1.5 Isodiol International Recent Development
11.2 Canopy Growth Corporation
11.2.1 Canopy Growth Corporation Company Detail
11.2.2 Canopy Growth Corporation Business Overview
11.2.3 Canopy Growth Corporation Cannabidiol (CBD) Edibles Introduction
11.2.4 Canopy Growth Corporation Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.2.5 Canopy Growth Corporation Recent Development
11.3 Aurora Cannabis
11.3.1 Aurora Cannabis Company Detail
11.3.2 Aurora Cannabis Business Overview
11.3.3 Aurora Cannabis Cannabidiol (CBD) Edibles Introduction
11.3.4 Aurora Cannabis Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.3.5 Aurora Cannabis Recent Development
11.4 MGC Pharma
11.4.1 MGC Pharma Company Detail
11.4.2 MGC Pharma Business Overview
11.4.3 MGC Pharma Cannabidiol (CBD) Edibles Introduction
11.4.4 MGC Pharma Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.4.5 MGC Pharma Recent Development
11.5 Creso Pharma
11.5.1 Creso Pharma Company Detail
11.5.2 Creso Pharma Business Overview
11.5.3 Creso Pharma Cannabidiol (CBD) Edibles Introduction
11.5.4 Creso Pharma Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.5.5 Creso Pharma Recent Development
11.6 Cronos Group
11.6.1 Cronos Group Company Detail
11.6.2 Cronos Group Business Overview
11.6.3 Cronos Group Cannabidiol (CBD) Edibles Introduction
11.6.4 Cronos Group Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.6.5 Cronos Group Recent Development
11.7 Chill Brands
11.7.1 Chill Brands Company Detail
11.7.2 Chill Brands Business Overview
11.7.3 Chill Brands Cannabidiol (CBD) Edibles Introduction
11.7.4 Chill Brands Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.7.5 Chill Brands Recent Development
11.8 Curaleaf
11.8.1 Curaleaf Company Detail
11.8.2 Curaleaf Business Overview
11.8.3 Curaleaf Cannabidiol (CBD) Edibles Introduction
11.8.4 Curaleaf Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.8.5 Curaleaf Recent Development
11.9 Green Thumb Industries
11.9.1 Green Thumb Industries Company Detail
11.9.2 Green Thumb Industries Business Overview
11.9.3 Green Thumb Industries Cannabidiol (CBD) Edibles Introduction
11.9.4 Green Thumb Industries Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.9.5 Green Thumb Industries Recent Development
11.10 Tilray
11.10.1 Tilray Company Detail
11.10.2 Tilray Business Overview
11.10.3 Tilray Cannabidiol (CBD) Edibles Introduction
11.10.4 Tilray Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.10.5 Tilray Recent Development
11.11 Ecofibre Limited
11.11.1 Ecofibre Limited Company Detail
11.11.2 Ecofibre Limited Business Overview
11.11.3 Ecofibre Limited Cannabidiol (CBD) Edibles Introduction
11.11.4 Ecofibre Limited Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.11.5 Ecofibre Limited Recent Development
11.12 ENDOCA
11.12.1 ENDOCA Company Detail
11.12.2 ENDOCA Business Overview
11.12.3 ENDOCA Cannabidiol (CBD) Edibles Introduction
11.12.4 ENDOCA Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.12.5 ENDOCA Recent Development
11.13 Elixinol
11.13.1 Elixinol Company Detail
11.13.2 Elixinol Business Overview
11.13.3 Elixinol Cannabidiol (CBD) Edibles Introduction
11.13.4 Elixinol Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.13.5 Elixinol Recent Development
11.14 Folium Biosciences
11.14.1 Folium Biosciences Company Detail
11.14.2 Folium Biosciences Business Overview
11.14.3 Folium Biosciences Cannabidiol (CBD) Edibles Introduction
11.14.4 Folium Biosciences Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.14.5 Folium Biosciences Recent Development
11.15 NuLeaf Naturals
11.15.1 NuLeaf Naturals Company Detail
11.15.2 NuLeaf Naturals Business Overview
11.15.3 NuLeaf Naturals Cannabidiol (CBD) Edibles Introduction
11.15.4 NuLeaf Naturals Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.15.5 NuLeaf Naturals Recent Development
11.16 PharmaHemp
11.16.1 PharmaHemp Company Detail
11.16.2 PharmaHemp Business Overview
11.16.3 PharmaHemp Cannabidiol (CBD) Edibles Introduction
11.16.4 PharmaHemp Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.16.5 PharmaHemp Recent Development
11.17 Happy Hemp
11.17.1 Happy Hemp Company Detail
11.17.2 Happy Hemp Business Overview
11.17.3 Happy Hemp Cannabidiol (CBD) Edibles Introduction
11.17.4 Happy Hemp Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.17.5 Happy Hemp Recent Development
11.18 Purekana
11.18.1 Purekana Company Detail
11.18.2 Purekana Business Overview
11.18.3 Purekana Cannabidiol (CBD) Edibles Introduction
11.18.4 Purekana Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.18.5 Purekana Recent Development
11.19 CV Sciences
11.19.1 CV Sciences Company Detail
11.19.2 CV Sciences Business Overview
11.19.3 CV Sciences Cannabidiol (CBD) Edibles Introduction
11.19.4 CV Sciences Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.19.5 CV Sciences Recent Development
11.20 CHARLOTTE鈥橲 WEB
11.20.1 CHARLOTTE鈥橲 WEB Company Detail
11.20.2 CHARLOTTE鈥橲 WEB Business Overview
11.20.3 CHARLOTTE鈥橲 WEB Cannabidiol (CBD) Edibles Introduction
11.20.4 CHARLOTTE鈥橲 WEB Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.20.5 CHARLOTTE鈥橲 WEB Recent Development
11.21 Colorado Botanicals
11.21.1 Colorado Botanicals Company Detail
11.21.2 Colorado Botanicals Business Overview
11.21.3 Colorado Botanicals Cannabidiol (CBD) Edibles Introduction
11.21.4 Colorado Botanicals Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.21.5 Colorado Botanicals Recent Development
11.22 PLUS Products Wonders
11.22.1 PLUS Products Wonders Company Detail
11.22.2 PLUS Products Wonders Business Overview
11.22.3 PLUS Products Wonders Cannabidiol (CBD) Edibles Introduction
11.22.4 PLUS Products Wonders Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.22.5 PLUS Products Wonders Recent Development
11.23 Balance CBD
11.23.1 Balance CBD Company Detail
11.23.2 Balance CBD Business Overview
11.23.3 Balance CBD Cannabidiol (CBD) Edibles Introduction
11.23.4 Balance CBD Revenue in Cannabidiol (CBD) Edibles Business (2019-2024)
11.23.5 Balance CBD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Isodiol International
Canopy Growth Corporation
Aurora Cannabis
MGC Pharma
Creso Pharma
Cronos Group
Chill Brands
Curaleaf
Green Thumb Industries
Tilray
Ecofibre Limited
ENDOCA
Elixinol
Folium Biosciences
NuLeaf Naturals
PharmaHemp
Happy Hemp
Purekana
CV Sciences
CHARLOTTE鈥橲 WEB
Colorado Botanicals
PLUS Products Wonders
Balance CBD
听
听
*If Applicable.
